ALSO IN THIS MONTH'S ISSUE

• New Swipes At Rx Industry Despite Stable Costs

  On the last full day of President Trump’s tumultuous presidency, CMS released a proposal to dramatically restrict access to Part D drugs for patients with serious medical conditions.

• Never Let Success Go To Your Head — Or Failure Get To Your Heart

  We all know most biotech ventures end in failure, but this does not make it any easier when you experience one, especially as a CEO.

• Tips For Biotechs Considering Building Their Own Facilities

  The engineering discipline and technical skills needed to build a new biopharma facility are generally absent within a startup biotech. Here are some key issues to consider when tackling this daunting challenge.

• The Hidden Real-World Reasons For Poor Clinical Trial Diversity

  To achieve better outcomes and health equity for historically underserved populations, we must address the not widely acknowledged, hidden, real-world reasons for such poor diversity in clinical trials.

• Leading With Data And Digital In The Life Sciences

  In this first article of our series on data sciences and AI, we define common discipline and technology terms and talk about what kind of leadership is necessary.